Amgen Inc. (NASDAQ:AMGN) is one of the These 10 Stocks Took A Shocking Fall. Amgen Inc. extended its losing streak to a ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...

Key Takeaways One shot a month of an experimental drug yielded promising results in a new clinical trialThe drug, called ...

To get a sense of who is truly in control of Amgen Inc. (NASDAQ:AMGN), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company ...

Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

Retired pro football hall-of-famer Barry Sanders revealed he had a heart attack in 2024. But now he working to help other ...

Thousand Oaks, California Wednesday, June 25, 2025, 13:00 Hrs [IST] ...

In a major win for AI companies, a federal judge in San Francisco ruled on Monday that Anthropic’s use of millions of copyrighted books —without writers’ permission— to train its AI models was legal ...